Salarius Pharmaceuticals, Inc. Common Stock

SLRX US79400X3052

💰
Capitalization
Small-cap

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

🔗
Website
https://www.salariuspharma.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
1
🙍
Insiders
1
Person Price Shares Total Published Completed
Rosenblum Mark J
EX VP 		0.80
USD 		20,000
Bought 		16,000
USD 		20/11/2025 20/11/2025
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Salarius Pharmaceuticals, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last
52W Low
52W High
All-Time Low
All-Time High
As of
2025-11-20
Company Insiders
Name Stats Turnover Average First Last
Rosenblum Mark J
1 transactions
Buy 100% Sell 0%
16.00K 16.00K 20/11/2025 20/11/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.